- Home
- / Harbin Pharmaceutical Group Renmin Tongtai Pharmaceutical
Harbin Pharmaceutical Group Renmin Tongtai Pharmaceutical
Stock Price
¥6.3
2024-10-29
Market Capitalization
¥3.6 B
2024-10-29
Revenue
¥10.3 B
FY, 2025
Harbin Pharmaceutical Group Renmin Tongtai Pharmaceutical Summary
Company Summary
- Overview
- Harbin Pharmaceutical Group Renmin Tongtai Pharmaceutical (哈药集团人民同泰医药股) is a retail and wholesale company that distributes pharmaceutical products. It offers herbal medicines, biochemical drugs, medical equipment, health care products, etc.
- Type
- Public
- Status
- Active
- Founded
- 1995
- HQ
- Ha Er Bin Shi, CN | view all locations
- Website
- http://www.hyrmtt.com.cn
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Ha Er Bin Shi, Hei Long Jiang Sheng HQ
China
Ha Yao Lu, Dao Li Qu
Harbin Pharmaceutical Group Renmin Tongtai Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥2.8B
- Gross profit (Q1, 2026)
- ¥217.9M
- Net income (Q1, 2026)
- ¥48.5M
- Cash (Q1, 2026)
- ¥883.9M
- EBIT (Q1, 2026)
- ¥71.8M
- Enterprise value
- $4.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026